Featured Question

How should we interpret and apply to practice the new data reported at ASCO 2014, focusing on initiating chemotherapy along with hormone therapy in men with newly metastatic prostate cancer? For which patients should or should we not use this treatment approach?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities


An Update on Clinical Trials Evaluating Chemotherapy-Free Approaches to NHL

Course Director
Anas Younes, MD
Memorial Sloan-Kettering Cancer Center
New York, New York


State of the Science in Retinal Disorders: Latest Advances in the Treatment of DME, AMD, and BRVO

Course Director
Carl Regillo, MD
Thomas Jefferson University
Wills Eye Hospital
Philadelphia, Pennsylvania


Q&A: Overcoming Challenges in the Treatment of Major Depressive Disorder

Course Director
Ian A. Cook, MD
David Geffen School of Medicine at UCLA
Semel Institute for Neuroscience and Human Behavior
UCLA Brain Research Institute
Los Angeles, California


Refining the Management of Patients With CLL: Update on Prognostic/Predictive Factors and New Therapies

Course Director
William G. Wierda, MD, PhD
Professor, Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas


Practical Guidance for Overcoming Challenging Patient-Care Issues in MS

Course Director
Daniel Ontaneda, MD, MS
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, Ohio


Translating an Improved Understanding of Disease Biology Into New Targets and Combinations for the Treatment of Advanced Skin Cancers

Course Director
Antoni Ribas, MD, PhD
Jonsson Comprehensive Cancer Center
University of California Los Angeles
Los Angeles, California


Challenging Cases in Multiple Sclerosis

Course Director
Aaron E. Miller, MD
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai School of Medicine
New York, New York